Serological Evaluation of Toxoplasmosis and Related Risk Factors Among HIV+/AIDS Patients in Northern Iran.

Hasan Rafati-SajediBijan Majidi-ShadReza Jafari-ShakibZahra Atrkar-RoshanMohammad Reza MahmoudiSeyed Mahmood Rezvani

Published in: Acta parasitologica (2021)

None of the T. gondii IgM-positive HIV patients received anti-Toxoplasma prophylaxis. This finding highlights the importance of T. gondii infection surveillance in HIV patients. Regarding the high prevalence of toxoplasmosis in the study population, educational efforts are recommended to prevent reactivation or acquiring primary infection and developing severe cases of toxoplasmosis in immunocompromised HIV+/AIDS patients.

Keyphrases

hiv aids
end stage renal disease
newly diagnosed
ejection fraction
antiretroviral therapy
chronic kidney disease
risk factors
prognostic factors
peritoneal dialysis
hiv infected
hepatitis c virus
public health
early onset
south africa
hiv testing